Table 4.
Total costs estimated in base case scenarios with and without RefluxStop and budget impact
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|
| Eligible population | 926,573 | 946,037 | 965,537 | 985,038 | 1,004,541 |
| Population expected to receive RefluxStop | 42 | 126 | 250 | 401 | 578 |
| Cost of treatment pathway without RefluxStop | €384,012,573 | €382,736,989 | €360,706,454 | €339,332,403 | €318,224,668 |
| Cost of treatment pathway with RefluxStop | €384,255,213 | €383,215,846 | €361,417,105 | €340,191,446 | €319,229,614 |
| Nominal net budget impact | €242,641 | €478,858 | €710,651 | €859,043 | €1,004,946 |
| Net budget impact as percentage of SSN spending for GERD treatment | 0.063% | 0.125% | 0.197% | 0.253% | 0.316% |
GERD gastroesophageal reflux disease, SSN Italian National Health Service